Adnan Kilani

8PUBLICATIONS
11CO-AUTHORS
Haematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Optical technologyVision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 16, 2026
Oral belzutifan treatment in von hippel-lindau-associated retinal hemangioblastoma: a promising approach.

|Feb 27, 2026
Short-term real-world outcomes of switching to faricimab in anti-VEGF-refractory retinal vein occlusion: a prospective study.

Adnan Kilani, Abdelrahman Assaf, Denise Vogt

|Jan 12, 2026
VEGF-inhibitor switch trial in poor-responsive neovascular age-related macular degeneration: assessing brolucizumab vs. faricimab: VISTA study.

Adnan Kilani, Denise Vogt, Vasiliki Moysidi

|Nov 13, 2025
Potential sustained benefits of early targeted panretinal photocoagulation in combination with anti-VEGF in macular edema secondary to retinal vein occlusion: 48-month results of a retrospective comparative study.

Adnan Kilani, Koray Bayhan, Efstathios Vounotrypidis

|Apr 26, 2025
Keratometry Changes Between Year Seven and Twelve After Corneal Crosslinking in Patients with Keratoconus.

Lukas Neuhann, Diana Vogel, Jens Dreyhaupt

|May 28, 2024
The role of multimodal imaging in characterization and monitoring of choroidal neovascularization secondary to angioid streaks.

Adnan Kilani, Denise Vogt, Armin Wolf

Pageof 2

Frequent Collaborators

4 joint publications

Armin Wolf

3 joint publications

Efstathios Vounotrypidis

2 joint publications

Denise Vogt

2 joint publications

Christian Enders